2021 annual financial data
iBio 2021 Operating margin
Direct answer
Operating margin was -1,312.15%.
Operating income was -31,111,000 USD and net income was -23,207,000 USD.
Operating cash flow was -30,064,000 USD.
Get free iBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,371,000 USD
- Operating income
- -31,111,000 USD
- Net income
- -23,207,000 USD
- Operating cash flow
- -30,064,000 USD